Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Extranodal Nasal NK/T Cell Lymphoma

National Cancer Centre, SingaporeSmall moleculePhase 4 / ApprovedDormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

50 Active assets in the Extranodal Nasal NK/T Cell Lymphoma cohort.

Asset / SponsorPhaseRating
PEGASPARGASE
CStone Pharmaceuticals
Phase 4BBB
Dexasone
Mingzhi Zhang
Phase 4BBB
Tucidinostat
Ruijin Hospital
Phase 4BB
Etoposide
Tarapeutics Science Inc.
Phase 4BB
LENALIDOMIDE
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4BB

View all 50 →

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaActive
BBB
Indicative · Phase 4
78 / 100
View asset →
primary peritoneal carcinomaActive
BBB
Indicative · Phase 3
77 / 100
View asset →
adenocarcinomaActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →